CClinicalTrials.gg
CompletedNCT05887076Updated Oct 18, 2024

Postoperative Delirium After Kidney Transplantation

An observational study in Post-operative Delirium, sponsored by Charite University, Berlin, Germany. Completed at 2 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-18.

Sponsored by Charite University, Berlin, Germany · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
362
Ages
18 Years and older
Sex
All
01

Study summary

This project is a retrospective evaluation of the routine data of patients who underwent a kidney transplant at the Charité Campus Mitte between January 2015 and December 2019 (until the corona pandemic).

Read the detailed description

Post-anesthetic complications such as delirium can occur in patients after kidney transplantation. We would therefore like to characterize pathophysiological changes after transplantation of the kidneys and, if necessary, gain diagnostic and therapeutic knowledge. The purpose is to study postoperative delirium after kidney transplantation.

02

Conditions studied

  • Post-operative Delirium
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's enrollment of 362 is above the median of 200 across 418 observational studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Male and female patients 18 years and older who underwent kidney transplantation

Inclusion criteria

  • All patients 18 years and older who underwent kidney transplantation and who were admitted to Post-intensive care unit or to an Intensive care unit at the Campus Charité Mitte

Exclusion criteria

Exclusion Criteria:

  • Incomplete data records of the parameters to be determined
  • Underage Patients
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
362 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of delirium

    Incidence of delirium is recorded from validated delirium scores.

    Time frame: 2015 - 2019

Secondary outcomes

  1. Duration of delirium

    Duration of delirium is recorded in days.

    Time frame: 2015 - 2019

  2. Severity of delirium

    Severity of delirium is recorded from validated delirium scores.

    Time frame: 2015 - 2019

  3. Intraoperative parameter

    Intraoperative parameter are recorded from patients with delirium.

    Time frame: 2015 - 2019

  4. Anesthesia

    Anesthesia is recorded from patient files of patients with delirium.

    Time frame: 2015 - 2019

  5. Anesthesiological parameters

    Anesthesiological parameters are recorded from patient files of patients with delirium.

    Time frame: 2015 - 2019

  6. Immunosupressive therapy

    Immunosupressive therapy is recorded in patients with delirium.

    Time frame: 2015 - 2019

  7. Delirium treatment

    Delirium treatment is recorded peri-operatively.

    Time frame: 2015 - 2019

  8. Pain teatment

    Pain treatment is recorded peri-operatively.

    Time frame: 2015 - 2019

  9. Intensive care unit stay

    Length of intensive care unit stay is measured in days.

    Time frame: 2015 - 2019

  10. Hospital stay

    Length of hospital stay is measured in days.

    Time frame: 2015 - 2019

  11. Mortality

    Mortality is measured within the hospital

    Time frame: 2015 - 2019

07

Study locations

2 sites
  • Department of Anaesthesiology and Intensive Care Medicine CCM, Charite - Universitätsmedizin
    Berlin, 10117, Germany
  • Medical Clinic with a focus on Nephrology and Internal Intensive Care Medicine
    Berlin, 10117, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05887076
Lead sponsor
Charite University, Berlin, Germany
Responsible party
Claudia Spies (Head of the Department of Anaesthesiology and Intensive Care Medicine CCM/CVK, Charite University, Berlin, Germany) — Principal investigator
First posted
Jun 2, 2023
Start date
May 24, 2023
Primary completion
Dec 19, 2023
Completion
Dec 19, 2023
Last update
Oct 18, 2024

Study contacts

Claudia Spies, MD, Prof.
study director · Charite University, Berlin, Germany

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion